sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> protein therapeutics market

report

Protein Therapeutics Market, by Therapeutic Proteins (Monoclonal Antobodies (mAbs), Erythropoietin (EPO), Insulin, Interferon (IFN), Human Growth Hormone (HGH), Follicle Stimulating Hormone (FSH), Blood Clotting Factors) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

HC288 March 2017 100+ FREE 10% CUSTOMIZATION

Protein therapeutics market is set to grow in the forecast period as its demand is increasing and there's increase in the investment on this market. Protein therapeutics is helpful in rare, life-threatening, and genetic diseases. North America and Europe are the top consumers of protein therapeutics because of better healthcare infrastructure and rise of chronic diseases among their citizens. Asia-Pacific is supposed to have a good growth rate in future for the protein therapeutics market because of large population and improving income levels.

The report on the global Protein therapeutics market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The key reasons for the growth of protein therapeutics market are favorable regulations, technological advancements in the field of healthcare, increasing geriatric population, and increase in the chronic diseases such as diabetes, cancer, and cardiovascular diseases.
  • Rise in the government expenditure on healthcare in developing economies is one of the key growth opportunities in the protein therapeutics market.
  • However, the protein therapeutics market will be hampered by the cost of production and the side effects.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s protein therapeutics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the protein therapeutics market by the following segments:

  • Protein Therapeutics Market, by Therapeutic Proteins
    • Monoclonal Antobodies (mAbs)
    • Erythropoietin (EPO)
    • Insulin
    • Interferon (IFN)
    • Human Growth Hormone (HGH)
    • Follicle Stimulating Hormone (FSH)
    • Blood Clotting Factors

KEY MARKET PLAYERS

Key players in the protein therapeutics market include:

  • Novo Nordisk
  • Johnson & Johnson
  • Eli Lilly & Company
  • Roche
  • Group Biogen Idec Inc.
  • Sanofi-Aventis
  • Merck Serono S.A.
  • Amgen Inc.
  • Abbott Laboratories
  • Pfizer

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • MIDDLE EAST & AFRICA
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa
  • LATIN AMERICA
    • Brazil
    • Rest of Latin America

TRENDING RELATED REPORT

Molecular Diagnostics Market, by Products (Reagents, Consumables, Instruments, Systems), Technologies (PCR, INAAT, Microarrays, Immunochemical, Sequencing), Applications (Infectious Diseases, Oncology, Genetic Testing, Blood Screening, Microbiology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Product Roadmap
  5. PROTEIN THERAPEUTICS MARKET, BY THERAPEUTIC PROTEINS
    1. Segment Share
    2. Therapeutic Proteins
      1. Monoclonal Antobodies (mAbs)
      2. Erythropoietin (EPO)
      3. Insulin
      4. Interferon (IFN)
      5. Human Growth Hormone (HGH)
      6. Follicle Stimulating Hormone (FSH)
      7. Blood Clotting Factors
  6. PROTEIN THERAPEUTICS MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Therapeutic Proteins
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K
        4. Rest of Europe
      2. By Therapeutic Proteins
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Therapeutic Proteins
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Therapeutic Proteins
  7. COMPETITIVE LANDSCAPE
    1. Market Share Analysis, 2015 (%)
    2. Key Innovators
  8. KEY MARKET PLAYERS
    1. Novo Nordisk
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Johnson & Johnson
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Eli Lilly & Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Roche
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Group Biogen Idec Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Sanofi-Aventis
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Merck Serono S.A.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Amgen Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Pfizer
      1. Overview
      2. Key Strategies
      3. Recent Developments
  9. SCALAR 360 DEGREE MARKET PERSPECTIVE
  10. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us